Arvinas, Inc.

ARVNNASDAQHealthcare● Active

$7.15

$-0.27(-3.64%)

Market Cap$461326566

P/E Ratio—

52W High$14.51

52W Low$6.06

Avg Volume889K

Open$7.49

Beta1.75

Employees Ownership Insider Trades

Arvinas, Inc. (ARVN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ARVN · as of Feb 24, 2026

Latest filing snapshot

246

-184-42.79%vs prior year

Arvinas, Inc. (ARVN) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

246

Change (1Y)

-184

Growth % (1Y)

-42.79%

Revenue / Employee

$1.07M

Net Income / Employee

$-328.5K

Market Cap

$461M

ARVN Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-24	2025-12-31	246	-184	-42.79%
2025-02-11	2024-12-31	430	-15	-3.37%
2024-02-27	2023-12-31	445	+30	+7.23%
2023-02-23	2022-12-31	415	+135	+48.21%
2022-02-28	2021-12-31	280	+101	+56.42%
2021-03-01	2020-12-31	179	+46	+34.59%
2020-03-16	2019-12-31	133	+50	+60.24%
2019-03-26	2018-12-31	83	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

DNA

Ginkgo Bioworks Holdings, Inc.

Day One Biopharmaceuticals, Inc.

Astria Therapeutics, Inc.

78$718M #7

AVBP

ArriVent BioPharma, Inc. Common Stock

52$1.4B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ARVN peer comparison

About ARVN employees

ARVN Employees · Headcount

Arvinas, Inc. (ARVN) employee data is sourced from the annual SEC 10-K filing. As of 2025, Arvinas, Inc. had 246 full-time employees globally. Full-time employees only. Global consolidated headcount.

Arvinas, Inc. employs 246 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.07M, reflecting the company's operational efficiency.

Arvinas, Inc.'s workforce decreased by 184 (42.79%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Arvinas, Inc.'s revenue per employee of $1.07M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ARVN Employees · 5 questions

As of the latest SEC 10-K filing (2025), Arvinas, Inc. had 246 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Arvinas, Inc. employee counthow many employees does Arvinas, Inc. haveARVN total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-24